| Sep 12 |
Summit Therapeutics jumps 4%, raises $235M
|
| Sep 12 |
Summit Therapeutics Raises $235 Million
|
| Sep 11 |
Summit Therapeutics Options Trading: A Deep Dive into Market Sentiment
|
| Sep 10 |
Summit Hits Record High on Lung Cancer Drug Topping Merck's Keytruda
|
| Sep 10 |
MRK Stock Dips After SMMT's Cancer Drug Outshines Keytruda in Study
|
| Sep 10 |
Company News for Sep 10, 2024
|
| Sep 10 |
Is Summit Therapeutics a Buy Now?
|
| Sep 9 |
Why Summit Therapeutics Rocketed Over 60% Today
|
| Sep 9 |
A Better Drug Than Merck’s Blockbuster Keytruda? Not So Fast
|
| Sep 9 |
Summit a ‘top pick’ at Citi after ‘unprecedented’ trial results, bull rally
|
